Photoactivation in Chemotherapeutic Compounds for Cancer Treatment: Opportunities Beyond Photodynamic Therapy
Bioinorganic Chemistry and Applications · 2026-01 · 2026 (1)
DOI: 10.1155/bca/7161202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioinorganic Chemistry and Applications, online erschienen am 08.03.2026. Verfasst von Simon Ngigi Mbugua und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Materials Science, Technical University of Kenya, P.O. Box 52428-00200, Nairobi, Kenya, tukenya.ac.ke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Photoactivation is the stimulation or regulation of a chemical or a chemical process by utilizing light of specific wavelength that corresponds to an absorbance optimum of the agent being used and can penetrate into tissues. In cancer therapy, photoactivatable drugs utilize this phenomenon by allowing the temporal and spatial regulation of their cytotoxicity using irradiation. Therefore, in order to reduce the adverse effects of platinum medications, photoactivatable anticancer pharmaceuticals, which might be site‐activated in the tumour region, are a viable option. This paper summarizes different types of photoactivatable anticancer compounds that would produce an active version of a drug by the process of photouncaging. The mode of photoactivation and rationale for drug design are summarized. The effects of typical complexes on cellular pathways, photocytotoxicity and dark cytotoxicity are explored. When compared to traditional Pt(II) anticancer medications, photoactivatable anticancer compounds provide a number of benefits, including ability to overcome drug resistance, and in situ monitoring of drug accumulation and activation inside cells. This review also covers the design approaches, synthesis techniques, photoresponsiveness and antitumour effectiveness of various photochemotherapeutic compounds. Future developments and challenges in incorporating photoresponsive metal complexes are also covered. This detailed review aims at encouraging further thorough investigation into this intriguing area of study by offering a summary of current developments in the design and development of photoresponsive compounds for cancer treatment and future clinical prospects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemistry and Materials Science, Technical University of Kenya, P.O. Box 52428-00200, Nairobi, Kenya, tukenya.ac.ke.
- School of Mathematics and Physical Sciences, Jomo Kenyatta University of Agriculture and Technology, P.O. Box 62, Nairobi, 000-00200, Kenya, jkuat.ac.ke.
ORCID-Profile: Simon Ngigi Mbugua
Zitieren
APA
Mbugua, S. N., & Nyawade, E. A. (2026). Photoactivation in Chemotherapeutic Compounds for Cancer Treatment: Opportunities Beyond Photodynamic Therapy. Bioinorganic Chemistry and Applications, 2026(1). https://doi.org/10.1155/bca/7161202
Vancouver
Mbugua SN, Nyawade EA. Photoactivation in Chemotherapeutic Compounds for Cancer Treatment: Opportunities Beyond Photodynamic Therapy. Bioinorganic Chemistry and Applications. 2026;2026(1). doi:10.1155/bca/7161202
BibTeX
@article{Mbugua2026,
author = {Mbugua, Simon Ngigi and Nyawade, Eunice Adhiambo},
title = {Photoactivation in Chemotherapeutic Compounds for Cancer Treatment: Opportunities Beyond Photodynamic Therapy},
journal = {Bioinorganic Chemistry and Applications},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bca/7161202}
}
EUVIMED